论文信息 - A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. - 字舞流文

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube.

B. Monk | R. Wenham | M. Einstein | A. Secord | T. Herzog | B. Childs | P. Rose | L. Roman | M. Bell | P. Braly | R. Drake | J. Hines